Viral Infections
RSSArticles
-
Why Some Children Develop Severe COVID-19 Disease
Severe outcomes included cardiovascular complications, neurologic complications, respiratory problems, and infectious-related issues. Those with pre-existing chronic disease, older age, and longer symptom duration put them at serious risk for severe outcomes.
-
ACC Publishes Guidance on Managing Cardiovascular Ailments Post-COVID Infection
Expert panel created document to help clinicians manage patients with myocarditis and other long COVID problems associated with SARS-CoV-2.
-
Rats in Washington, DC? The Seoul of the Issue
The Centers for Disease Control and Prevention has reported cases of the Seoul hantavirus in Washington, DC.
-
Bebtelovimab Injection
The FDA has issued an emergency use authorization for a monoclonal antibody that demonstrated efficacy against the omicron variant of COVID-19.
-
Herpes Simplex Virus 2 Meningitis in Adults
The incidence of herpes simplex virus 2 meningitis in adults in Denmark over a six-year period was 0.7/100,000 population per year, with 91% of cases occurring in the absence of immunocompromise.
-
Understanding Each COVID-19 Test’s Strengths and Weaknesses
Considering that testing over multiple days is not practical in the ED, clinicians with access to relatively rapid RT-PCR testing probably will opt for the more sensitive test. However, the antigen test offers a good option to urgent care centers or EDs that lack access to a sophisticated lab.
-
Booster Doses Effective Against Omicron
While vaccination provides protection against infection with omicron variant of SARS-CoV-2, high level protection from a need for hospitalization requires a booster dose.
-
Omicron: Get Your Booster Dose!
While vaccination provides protection against the omicron variant of SARS-CoV-2, high-level protection from a need for hospitalization requires receipt of a booster dose.
-
Third Documented HIV Remission Case Emerges
Woman with acute myeloid leukemia underwent stem cell transplant, which apparently sent the virus into remission.
-
Multiple Sclerosis and Immune Response to COVID-19 Vaccination
A large group of patients with multiple sclerosis taking various disease-modifying therapies did not respond uniformly to COVID-19 vaccination.